Reactive oxygen species and NADPH oxidase 4 induced by transforming growth factor β1 are the therapeutic targets of polyenylphosphatidylcholine in the suppression of human hepatic stellate cell activation
Remina Ikeda(Tottori University), Goshi Shiota(Regenerative Medicine Institute), Shizuka Matsuura(Tottori University), Yoshiaki Matsumi, Ichiro Hisatome(National Institute of Technology, Yonago College), Akihiro Kurimasa(Tohoku Medical and Pharmaceutical University Hospital), Yuta Arakaki, Scott L. Friedman(Icahn School of Medicine at Mount Sinai), Toshihiro Yasui, Hironaka Kawasaki(Sanin Rosai Hospital), Kyoko Ishii(Tohoku University), Yoshiko Hoshikawa(Tottori University), Yohei Kono(Tokyo Institute of Technology), Yusuke Mizuta(Tottori University), Junya Azumi(Asai Germanium Research Institute)
Cited by 28
Related Papers
Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury
|Journal of Biological Chemistry|2000|2.1k
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
|New England Journal of Medicine|2008|1.3k
Focal Gains of <i>VEGFA</i> and Molecular Classification of Hepatocellular Carcinoma
|Cancer Research|2008|712